 Thomas Jansson
Concepts (429)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Placenta | 85 | 2025 | 706 | 17.880 |
Why?
| | Fetal Growth Retardation | 39 | 2025 | 542 | 9.330 |
Why?
| | Trophoblasts | 40 | 2025 | 186 | 9.080 |
Why?
| | TOR Serine-Threonine Kinases | 44 | 2025 | 380 | 8.070 |
Why?
| | Fetal Development | 30 | 2025 | 283 | 6.840 |
Why?
| | Pregnancy | 123 | 2025 | 6256 | 5.200 |
Why?
| | Maternal-Fetal Exchange | 22 | 2021 | 159 | 4.930 |
Why?
| | Amino Acids | 22 | 2024 | 470 | 4.840 |
Why?
| | Amino Acid Transport System A | 12 | 2025 | 36 | 4.710 |
Why?
| | Diabetes, Gestational | 16 | 2023 | 306 | 4.350 |
Why?
| | Adiponectin | 14 | 2024 | 232 | 4.110 |
Why?
| | Insulin-Like Growth Factor Binding Protein 1 | 16 | 2023 | 26 | 3.620 |
Why?
| | Pregnancy Complications | 15 | 2024 | 487 | 3.590 |
Why?
| | Amino Acid Transport Systems | 14 | 2024 | 40 | 3.480 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 15 | 2024 | 115 | 3.110 |
Why?
| | Obesity | 24 | 2025 | 2847 | 3.030 |
Why?
| | Insulin | 28 | 2023 | 2313 | 2.980 |
Why?
| | Insulin-Like Growth Factor I | 16 | 2023 | 308 | 2.880 |
Why?
| | Glucose Intolerance | 5 | 2022 | 142 | 2.790 |
Why?
| | Maternal Nutritional Physiological Phenomena | 12 | 2024 | 168 | 2.740 |
Why?
| | Signal Transduction | 41 | 2025 | 4867 | 2.670 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 9 | 2023 | 59 | 2.500 |
Why?
| | Folic Acid | 7 | 2021 | 182 | 2.270 |
Why?
| | Fetal Macrosomia | 10 | 2023 | 60 | 2.220 |
Why?
| | Amino Acid Transport System L | 6 | 2025 | 18 | 2.180 |
Why?
| | Papio | 14 | 2021 | 97 | 2.050 |
Why?
| | Birth Weight | 13 | 2021 | 494 | 2.030 |
Why?
| | Pregnancy Proteins | 6 | 2022 | 37 | 1.960 |
Why?
| | Prenatal Exposure Delayed Effects | 9 | 2024 | 551 | 1.940 |
Why?
| | Fetus | 16 | 2024 | 764 | 1.850 |
Why?
| | Placental Insufficiency | 5 | 2019 | 111 | 1.810 |
Why?
| | Female | 128 | 2025 | 68274 | 1.800 |
Why?
| | Biological Transport | 17 | 2024 | 394 | 1.680 |
Why?
| | Folate Receptor 1 | 4 | 2019 | 14 | 1.660 |
Why?
| | Decidua | 7 | 2022 | 23 | 1.630 |
Why?
| | Cell Membrane | 11 | 2020 | 729 | 1.570 |
Why?
| | Fetal Weight | 7 | 2021 | 56 | 1.570 |
Why?
| | Placentation | 6 | 2021 | 44 | 1.520 |
Why?
| | Insulin Resistance | 10 | 2024 | 1164 | 1.500 |
Why?
| | Multiprotein Complexes | 6 | 2015 | 147 | 1.480 |
Why?
| | Glucose Transporter Type 1 | 5 | 2020 | 48 | 1.360 |
Why?
| | Animals | 61 | 2025 | 34708 | 1.340 |
Why?
| | Extracellular Vesicles | 2 | 2022 | 123 | 1.290 |
Why?
| | Down-Regulation | 8 | 2020 | 639 | 1.280 |
Why?
| | Folic Acid Deficiency | 3 | 2021 | 48 | 1.280 |
Why?
| | Receptors, Adiponectin | 4 | 2024 | 18 | 1.240 |
Why?
| | Fetal Nutrition Disorders | 3 | 2015 | 7 | 1.220 |
Why?
| | Phosphorylation | 23 | 2023 | 1686 | 1.170 |
Why?
| | Blood Glucose | 7 | 2023 | 2088 | 1.110 |
Why?
| | Heart Diseases | 2 | 2022 | 356 | 1.100 |
Why?
| | Fatty Liver | 2 | 2022 | 230 | 1.090 |
Why?
| | Diet, Protein-Restricted | 2 | 2021 | 11 | 1.030 |
Why?
| | Pregnancy Trimester, First | 6 | 2021 | 133 | 1.010 |
Why?
| | Intracellular Signaling Peptides and Proteins | 6 | 2025 | 422 | 1.000 |
Why?
| | Leucine | 7 | 2021 | 106 | 0.990 |
Why?
| | Humans | 102 | 2025 | 129078 | 0.980 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2021 | 817 | 0.970 |
Why?
| | Gestational Age | 14 | 2021 | 857 | 0.950 |
Why?
| | Docosahexaenoic Acids | 6 | 2024 | 81 | 0.920 |
Why?
| | Body Mass Index | 13 | 2024 | 2250 | 0.890 |
Why?
| | Cells, Cultured | 21 | 2021 | 4063 | 0.890 |
Why?
| | Adiposity | 4 | 2023 | 505 | 0.880 |
Why?
| | Lipid Metabolism | 7 | 2024 | 492 | 0.880 |
Why?
| | Reduced Folate Carrier Protein | 3 | 2019 | 9 | 0.870 |
Why?
| | Symporters | 1 | 2023 | 55 | 0.870 |
Why?
| | Pregnancy, Animal | 3 | 2014 | 53 | 0.850 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 2 | 2021 | 9 | 0.840 |
Why?
| | Caloric Restriction | 2 | 2015 | 108 | 0.820 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2023 | 138 | 0.790 |
Why?
| | Overnutrition | 1 | 2022 | 30 | 0.770 |
Why?
| | Glucose Transport Proteins, Facilitative | 2 | 2014 | 12 | 0.750 |
Why?
| | Mice | 19 | 2025 | 16583 | 0.740 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 18 | 0.720 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 3 | 2021 | 268 | 0.720 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 42 | 0.720 |
Why?
| | Pregnancy Trimester, Second | 2 | 2020 | 73 | 0.710 |
Why?
| | Liver | 6 | 2023 | 1835 | 0.710 |
Why?
| | N-Acetylglucosaminyltransferases | 1 | 2020 | 22 | 0.710 |
Why?
| | Fatty Acid Transport Proteins | 4 | 2018 | 19 | 0.710 |
Why?
| | Infant, Newborn | 19 | 2023 | 5707 | 0.700 |
Why?
| | Membrane Transport Proteins | 3 | 2023 | 148 | 0.700 |
Why?
| | Overweight | 3 | 2017 | 524 | 0.690 |
Why?
| | Serotonin | 2 | 2020 | 321 | 0.690 |
Why?
| | Food Deprivation | 3 | 2020 | 21 | 0.680 |
Why?
| | Leptin | 4 | 2015 | 217 | 0.680 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2020 | 23 | 0.680 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2020 | 55 | 0.660 |
Why?
| | Adult | 40 | 2025 | 35423 | 0.660 |
Why?
| | Mice, Inbred C57BL | 11 | 2024 | 5282 | 0.650 |
Why?
| | Phospholipids | 4 | 2024 | 210 | 0.640 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 2 | 2015 | 34 | 0.620 |
Why?
| | Glucose | 10 | 2022 | 976 | 0.620 |
Why?
| | Adaptor Proteins, Signal Transducing | 5 | 2015 | 395 | 0.600 |
Why?
| | Protein Kinases | 4 | 2019 | 305 | 0.600 |
Why?
| | PPAR gamma | 5 | 2022 | 182 | 0.600 |
Why?
| | Fatty Acid-Binding Proteins | 4 | 2018 | 68 | 0.600 |
Why?
| | Regulatory-Associated Protein of mTOR | 6 | 2019 | 18 | 0.590 |
Why?
| | Fusion Regulatory Protein 1, Light Chains | 2 | 2015 | 6 | 0.580 |
Why?
| | Infant, Premature | 2 | 2022 | 540 | 0.580 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2015 | 156 | 0.570 |
Why?
| | Mice, Obese | 4 | 2022 | 55 | 0.570 |
Why?
| | Fatty Acids, Unsaturated | 4 | 2018 | 93 | 0.570 |
Why?
| | Metabolic Diseases | 1 | 2018 | 106 | 0.560 |
Why?
| | Casein Kinase II | 7 | 2021 | 21 | 0.560 |
Why?
| | Specimen Handling | 1 | 2018 | 164 | 0.560 |
Why?
| | Organ Size | 8 | 2021 | 446 | 0.550 |
Why?
| | RNA Interference | 5 | 2021 | 448 | 0.550 |
Why?
| | Disease Models, Animal | 9 | 2022 | 3999 | 0.520 |
Why?
| | Homeostasis | 1 | 2020 | 605 | 0.520 |
Why?
| | Transcriptome | 3 | 2022 | 875 | 0.510 |
Why?
| | AMP-Activated Protein Kinases | 5 | 2022 | 187 | 0.510 |
Why?
| | Hormones | 2 | 2008 | 139 | 0.510 |
Why?
| | Chorionic Villi | 4 | 2019 | 22 | 0.500 |
Why?
| | Fetal Blood | 4 | 2024 | 315 | 0.500 |
Why?
| | Altitude | 1 | 2019 | 451 | 0.490 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 5 | 2015 | 59 | 0.490 |
Why?
| | RNA, Small Interfering | 6 | 2023 | 577 | 0.470 |
Why?
| | Diet, High-Fat | 5 | 2024 | 240 | 0.470 |
Why?
| | Rapamycin-Insensitive Companion of mTOR Protein | 5 | 2019 | 28 | 0.460 |
Why?
| | Proteome | 1 | 2018 | 423 | 0.450 |
Why?
| | Homocysteine | 2 | 2017 | 150 | 0.450 |
Why?
| | Weight Gain | 2 | 2015 | 504 | 0.450 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2013 | 28 | 0.440 |
Why?
| | Ubiquitination | 3 | 2022 | 96 | 0.430 |
Why?
| | Vitamin D | 1 | 2016 | 384 | 0.420 |
Why?
| | Nutritional Status | 1 | 2015 | 325 | 0.410 |
Why?
| | Gene Expression Regulation | 5 | 2021 | 2523 | 0.400 |
Why?
| | Proton-Coupled Folate Transporter | 3 | 2019 | 9 | 0.400 |
Why?
| | Primary Cell Culture | 6 | 2019 | 159 | 0.400 |
Why?
| | Dietary Supplements | 4 | 2024 | 533 | 0.400 |
Why?
| | Fatty Acids | 5 | 2022 | 415 | 0.400 |
Why?
| | Placental Circulation | 6 | 2019 | 63 | 0.400 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 3 | 2016 | 13 | 0.390 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2022 | 422 | 0.390 |
Why?
| | Male | 23 | 2025 | 63248 | 0.390 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 2016 | 0.380 |
Why?
| | Pregnancy in Diabetics | 3 | 2021 | 118 | 0.380 |
Why?
| | Microvilli | 4 | 2019 | 75 | 0.360 |
Why?
| | Case-Control Studies | 5 | 2021 | 3336 | 0.360 |
Why?
| | PPAR alpha | 4 | 2015 | 58 | 0.350 |
Why?
| | STAT3 Transcription Factor | 2 | 2014 | 187 | 0.350 |
Why?
| | Biological Availability | 2 | 2023 | 129 | 0.350 |
Why?
| | Cohort Studies | 6 | 2023 | 5400 | 0.340 |
Why?
| | Oleic Acid | 3 | 2014 | 38 | 0.340 |
Why?
| | Dietary Fats | 2 | 2008 | 302 | 0.330 |
Why?
| | Dietary Proteins | 1 | 2011 | 131 | 0.330 |
Why?
| | Ion Transport | 1 | 2009 | 57 | 0.330 |
Why?
| | Carrier Proteins | 5 | 2021 | 731 | 0.330 |
Why?
| | Hypoxia | 3 | 2022 | 1071 | 0.320 |
Why?
| | Rats, Wistar | 8 | 2021 | 396 | 0.310 |
Why?
| | Rats | 10 | 2021 | 5254 | 0.310 |
Why?
| | beta-Alanine | 2 | 2006 | 17 | 0.300 |
Why?
| | In Vitro Techniques | 5 | 2021 | 1061 | 0.300 |
Why?
| | RNA, Messenger | 6 | 2024 | 2702 | 0.300 |
Why?
| | Proteolysis | 2 | 2022 | 162 | 0.300 |
Why?
| | Gene Knockdown Techniques | 4 | 2025 | 315 | 0.300 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 2 | 2023 | 15 | 0.290 |
Why?
| | Amino Acid Transport Systems, Neutral | 1 | 2007 | 4 | 0.280 |
Why?
| | Endoplasmic Reticulum Stress | 2 | 2020 | 98 | 0.280 |
Why?
| | Food | 1 | 2009 | 169 | 0.280 |
Why?
| | Malaria, Falciparum | 2 | 2017 | 24 | 0.280 |
Why?
| | Choline | 2 | 2024 | 117 | 0.270 |
Why?
| | Hyperglycemia | 2 | 2007 | 321 | 0.270 |
Why?
| | Taurine | 1 | 2007 | 41 | 0.270 |
Why?
| | Protein Transport | 3 | 2021 | 424 | 0.260 |
Why?
| | Biological Transport, Active | 3 | 2015 | 72 | 0.260 |
Why?
| | Up-Regulation | 3 | 2015 | 850 | 0.260 |
Why?
| | Cesarean Section | 2 | 2022 | 180 | 0.260 |
Why?
| | CD36 Antigens | 2 | 2016 | 35 | 0.250 |
Why?
| | Adult Children | 2 | 2024 | 23 | 0.250 |
Why?
| | Hep G2 Cells | 7 | 2021 | 61 | 0.250 |
Why?
| | Hypoglycemic Agents | 3 | 2019 | 1208 | 0.250 |
Why?
| | DNA Methylation | 2 | 2023 | 602 | 0.240 |
Why?
| | Energy Intake | 1 | 2008 | 453 | 0.240 |
Why?
| | Chromatography, Liquid | 2 | 2023 | 366 | 0.240 |
Why?
| | Palmitic Acid | 2 | 2014 | 40 | 0.230 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2004 | 49 | 0.230 |
Why?
| | Protein Kinase C-alpha | 2 | 2021 | 37 | 0.230 |
Why?
| | Cell Hypoxia | 3 | 2021 | 238 | 0.230 |
Why?
| | Young Adult | 9 | 2024 | 12310 | 0.230 |
Why?
| | Tandem Mass Spectrometry | 2 | 2023 | 443 | 0.230 |
Why?
| | Gene Silencing | 4 | 2021 | 181 | 0.230 |
Why?
| | Maternal Age | 3 | 2021 | 121 | 0.220 |
Why?
| | Amino Acids, Essential | 1 | 2023 | 12 | 0.220 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2022 | 135 | 0.220 |
Why?
| | Term Birth | 2 | 2015 | 20 | 0.220 |
Why?
| | Embryonic Development | 2 | 2021 | 118 | 0.210 |
Why?
| | Umbilical Veins | 2 | 2014 | 61 | 0.210 |
Why?
| | Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 15 | 0.200 |
Why?
| | Body Weight | 3 | 2012 | 936 | 0.190 |
Why?
| | 3T3-L1 Cells | 1 | 2022 | 34 | 0.190 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2023 | 111 | 0.190 |
Why?
| | Sirolimus | 5 | 2020 | 194 | 0.190 |
Why?
| | Carnitine | 1 | 2022 | 75 | 0.190 |
Why?
| | Fetal Heart | 1 | 2022 | 53 | 0.190 |
Why?
| | Inflammation Mediators | 2 | 2015 | 503 | 0.190 |
Why?
| | Animals, Newborn | 2 | 2018 | 817 | 0.190 |
Why?
| | Glucose Tolerance Test | 1 | 2022 | 356 | 0.180 |
Why?
| | Intra-Abdominal Fat | 1 | 2022 | 89 | 0.180 |
Why?
| | Cardiomegaly | 1 | 2022 | 172 | 0.180 |
Why?
| | Infant, Low Birth Weight | 2 | 2019 | 134 | 0.180 |
Why?
| | Monoamine Oxidase | 1 | 2020 | 27 | 0.180 |
Why?
| | Biomarkers | 4 | 2024 | 3878 | 0.180 |
Why?
| | Testosterone | 2 | 2016 | 382 | 0.180 |
Why?
| | Triglycerides | 4 | 2023 | 519 | 0.180 |
Why?
| | Organogenesis | 1 | 2021 | 57 | 0.170 |
Why?
| | Infant | 4 | 2024 | 8997 | 0.170 |
Why?
| | Umbilical Cord | 1 | 2020 | 84 | 0.170 |
Why?
| | Cell Culture Techniques | 2 | 2021 | 350 | 0.170 |
Why?
| | Skinfold Thickness | 1 | 2020 | 49 | 0.170 |
Why?
| | Embryo, Mammalian | 1 | 2021 | 226 | 0.170 |
Why?
| | Adipocytes | 1 | 2022 | 204 | 0.170 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2022 | 361 | 0.170 |
Why?
| | Child, Preschool | 4 | 2024 | 10462 | 0.170 |
Why?
| | Myometrium | 1 | 2019 | 35 | 0.160 |
Why?
| | Pediatric Obesity | 2 | 2024 | 568 | 0.160 |
Why?
| | Metabolomics | 1 | 2024 | 594 | 0.160 |
Why?
| | Organelle Biogenesis | 1 | 2019 | 14 | 0.160 |
Why?
| | Immunohistochemistry | 3 | 2018 | 1697 | 0.160 |
Why?
| | Enzyme Activation | 3 | 2015 | 811 | 0.160 |
Why?
| | Protein Kinase C | 2 | 2021 | 258 | 0.160 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2019 | 52 | 0.160 |
Why?
| | Lysophosphatidylcholines | 1 | 2018 | 21 | 0.160 |
Why?
| | Myoblasts, Skeletal | 1 | 2018 | 12 | 0.160 |
Why?
| | Olive Oil | 1 | 2018 | 3 | 0.150 |
Why?
| | Electron Transport | 1 | 2019 | 111 | 0.150 |
Why?
| | Protein Interaction Maps | 1 | 2018 | 43 | 0.150 |
Why?
| | PPAR delta | 1 | 2018 | 5 | 0.150 |
Why?
| | Lipids | 1 | 2022 | 616 | 0.150 |
Why?
| | Tetrahydrofolates | 1 | 2018 | 18 | 0.150 |
Why?
| | Models, Biological | 4 | 2021 | 1704 | 0.150 |
Why?
| | Oxidative Phosphorylation | 1 | 2019 | 185 | 0.150 |
Why?
| | Exosomes | 1 | 2018 | 95 | 0.140 |
Why?
| | Piperidines | 1 | 2019 | 188 | 0.140 |
Why?
| | Child | 6 | 2024 | 20860 | 0.140 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2017 | 27 | 0.140 |
Why?
| | alpha-Linolenic Acid | 1 | 2017 | 8 | 0.140 |
Why?
| | Blood Platelets | 1 | 2020 | 370 | 0.140 |
Why?
| | Glyburide | 1 | 2017 | 35 | 0.140 |
Why?
| | Rats, Sprague-Dawley | 3 | 2007 | 2311 | 0.140 |
Why?
| | Mice, Inbred ICR | 1 | 2017 | 113 | 0.140 |
Why?
| | Arachidonic Acid | 1 | 2017 | 114 | 0.140 |
Why?
| | Pregnancy Complications, Parasitic | 1 | 2017 | 9 | 0.140 |
Why?
| | Protein Processing, Post-Translational | 3 | 2015 | 448 | 0.140 |
Why?
| | Phosphoproteins | 2 | 2011 | 326 | 0.140 |
Why?
| | Receptors, Calcitriol | 1 | 2016 | 53 | 0.130 |
Why?
| | Electroacupuncture | 1 | 2016 | 2 | 0.130 |
Why?
| | Muscle Contraction | 1 | 2019 | 426 | 0.130 |
Why?
| | Cholecalciferol | 1 | 2016 | 59 | 0.130 |
Why?
| | Resource Allocation | 1 | 2016 | 39 | 0.130 |
Why?
| | Prospective Studies | 2 | 2021 | 7070 | 0.130 |
Why?
| | Coenzyme A Ligases | 1 | 2016 | 13 | 0.130 |
Why?
| | Amino Acid Transport System y+L | 1 | 2015 | 4 | 0.130 |
Why?
| | Echocardiography | 1 | 2019 | 634 | 0.130 |
Why?
| | Fatty Acid Binding Protein 3 | 1 | 2015 | 5 | 0.130 |
Why?
| | Caspase 3 | 2 | 2014 | 241 | 0.130 |
Why?
| | Androgens | 1 | 2017 | 173 | 0.130 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 2015 | 13 | 0.130 |
Why?
| | Proteomics | 1 | 2022 | 988 | 0.130 |
Why?
| | Excitatory Amino Acids | 1 | 2015 | 7 | 0.130 |
Why?
| | Transport Vesicles | 1 | 2015 | 19 | 0.120 |
Why?
| | Diet | 3 | 2022 | 1205 | 0.120 |
Why?
| | Dietary Sucrose | 1 | 2015 | 47 | 0.120 |
Why?
| | Anti-Inflammatory Agents | 1 | 2019 | 468 | 0.120 |
Why?
| | Hepatocytes | 2 | 2014 | 215 | 0.120 |
Why?
| | Lipase | 1 | 2015 | 63 | 0.120 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2017 | 267 | 0.120 |
Why?
| | Autophagy | 1 | 2017 | 265 | 0.120 |
Why?
| | Heart | 1 | 2019 | 650 | 0.120 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2015 | 145 | 0.120 |
Why?
| | Interleukin-1beta | 2 | 2014 | 376 | 0.110 |
Why?
| | Analysis of Variance | 2 | 2017 | 1285 | 0.110 |
Why?
| | Myocardium | 1 | 2019 | 981 | 0.110 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2017 | 334 | 0.110 |
Why?
| | Ovarian Neoplasms | 1 | 2019 | 484 | 0.110 |
Why?
| | bcl-2-Associated X Protein | 1 | 2013 | 49 | 0.110 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2021 | 2421 | 0.110 |
Why?
| | Transfection | 1 | 2015 | 907 | 0.110 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2013 | 31 | 0.110 |
Why?
| | Receptor, IGF Type 1 | 3 | 2021 | 64 | 0.110 |
Why?
| | Ceramides | 1 | 2014 | 112 | 0.100 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2670 | 0.100 |
Why?
| | Blood Urea Nitrogen | 1 | 2012 | 53 | 0.100 |
Why?
| | Mitochondria | 1 | 2019 | 840 | 0.100 |
Why?
| | Apoptosis | 2 | 2019 | 2485 | 0.100 |
Why?
| | Protein Subunits | 1 | 2013 | 232 | 0.100 |
Why?
| | Energy Metabolism | 2 | 2015 | 837 | 0.100 |
Why?
| | Hyperandrogenism | 1 | 2012 | 18 | 0.100 |
Why?
| | Liver Neoplasms | 1 | 2017 | 637 | 0.100 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1629 | 0.100 |
Why?
| | Oxygen | 1 | 2017 | 913 | 0.100 |
Why?
| | MicroRNAs | 1 | 2018 | 669 | 0.100 |
Why?
| | Brain | 1 | 2023 | 2604 | 0.090 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2011 | 21 | 0.090 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2012 | 158 | 0.090 |
Why?
| | Phosphatidylcholines | 2 | 2023 | 147 | 0.090 |
Why?
| | Prognosis | 1 | 2019 | 3793 | 0.090 |
Why?
| | Colorado | 1 | 2020 | 4445 | 0.080 |
Why?
| | Stromal Cells | 2 | 2021 | 104 | 0.080 |
Why?
| | Mothers | 1 | 2015 | 723 | 0.080 |
Why?
| | Glucocorticoids | 1 | 2013 | 571 | 0.080 |
Why?
| | Inflammation | 2 | 2022 | 2696 | 0.070 |
Why?
| | Microscopy, Fluorescence | 2 | 2021 | 404 | 0.070 |
Why?
| | Immunity, Innate | 1 | 2014 | 804 | 0.070 |
Why?
| | Pregnancy Trimester, Third | 1 | 2008 | 105 | 0.070 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenases | 1 | 2007 | 3 | 0.070 |
Why?
| | Sex Factors | 1 | 2013 | 1950 | 0.070 |
Why?
| | Glucose Transporter Type 3 | 1 | 2007 | 13 | 0.070 |
Why?
| | Amino Acid Transport System y+ | 1 | 2007 | 8 | 0.070 |
Why?
| | Hyperlipoproteinemia Type I | 1 | 2007 | 7 | 0.070 |
Why?
| | Sex Characteristics | 2 | 2023 | 724 | 0.070 |
Why?
| | Fluorescent Antibody Technique | 2 | 2018 | 392 | 0.070 |
Why?
| | Uterus | 2 | 2019 | 204 | 0.070 |
Why?
| | Oxidative Stress | 2 | 2018 | 1221 | 0.070 |
Why?
| | Lipoprotein Lipase | 1 | 2007 | 59 | 0.070 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2018 | 170 | 0.070 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2006 | 20 | 0.070 |
Why?
| | Glucose Clamp Technique | 1 | 2007 | 195 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2013 | 3047 | 0.060 |
Why?
| | Mass Spectrometry | 2 | 2021 | 662 | 0.060 |
Why?
| | Cross-Sectional Studies | 3 | 2022 | 5036 | 0.060 |
Why?
| | Interviews as Topic | 1 | 2008 | 697 | 0.060 |
Why?
| | Lentivirus | 1 | 2025 | 52 | 0.060 |
Why?
| | Osmolar Concentration | 1 | 2004 | 166 | 0.060 |
Why?
| | Lactic Acid | 1 | 2006 | 296 | 0.060 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2004 | 194 | 0.060 |
Why?
| | Ephrin-A3 | 1 | 2024 | 1 | 0.060 |
Why?
| | Ephrins | 1 | 2024 | 7 | 0.060 |
Why?
| | Microscopy, Electron | 1 | 2004 | 419 | 0.060 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2017 | 165 | 0.060 |
Why?
| | Ether | 1 | 2023 | 7 | 0.060 |
Why?
| | Ethyl Ethers | 1 | 2023 | 4 | 0.060 |
Why?
| | Plasmalogens | 1 | 2023 | 6 | 0.060 |
Why?
| | Ethers | 1 | 2023 | 16 | 0.050 |
Why?
| | Lipocalin-2 | 1 | 2024 | 76 | 0.050 |
Why?
| | Connexins | 1 | 2024 | 53 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2023 | 74 | 0.050 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 2 | 2014 | 160 | 0.050 |
Why?
| | Electrolytes | 1 | 2003 | 57 | 0.050 |
Why?
| | Cell Cycle Proteins | 1 | 2007 | 576 | 0.050 |
Why?
| | Adipose Tissue | 1 | 2007 | 588 | 0.050 |
Why?
| | Body Composition | 1 | 2007 | 654 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 1974 | 0.050 |
Why?
| | Pregnancy, High-Risk | 1 | 2002 | 12 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2006 | 716 | 0.050 |
Why?
| | Insulin, Regular, Human | 1 | 2022 | 42 | 0.050 |
Why?
| | Pregnant Women | 1 | 2023 | 118 | 0.050 |
Why?
| | Insulin Receptor Substrate Proteins | 2 | 2013 | 59 | 0.050 |
Why?
| | MAP Kinase Signaling System | 2 | 2014 | 305 | 0.050 |
Why?
| | Maleimides | 1 | 2021 | 21 | 0.050 |
Why?
| | Cell Shape | 1 | 2021 | 55 | 0.050 |
Why?
| | Receptors, Erythropoietin | 1 | 2021 | 23 | 0.050 |
Why?
| | Norway | 1 | 2021 | 42 | 0.050 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2021 | 150 | 0.050 |
Why?
| | Metabolome | 1 | 2024 | 316 | 0.050 |
Why?
| | Esterification | 1 | 2020 | 11 | 0.050 |
Why?
| | Cholesterol | 1 | 2023 | 400 | 0.050 |
Why?
| | Parity | 1 | 2021 | 120 | 0.040 |
Why?
| | Epithelial Cells | 1 | 2007 | 1063 | 0.040 |
Why?
| | Reference Values | 1 | 2002 | 791 | 0.040 |
Why?
| | Erythropoietin | 1 | 2021 | 90 | 0.040 |
Why?
| | Receptors, Amino Acid | 1 | 2020 | 25 | 0.040 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 271 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 822 | 0.040 |
Why?
| | NF-kappa B | 2 | 2014 | 687 | 0.040 |
Why?
| | Neoplasms, Cystic, Mucinous, and Serous | 1 | 2019 | 25 | 0.040 |
Why?
| | Hippocampus | 1 | 2024 | 791 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2020 | 164 | 0.040 |
Why?
| | Erythrocytes | 1 | 2024 | 669 | 0.040 |
Why?
| | Sodium | 1 | 2020 | 205 | 0.040 |
Why?
| | Cell Cycle Checkpoints | 1 | 2019 | 95 | 0.040 |
Why?
| | Arachidonic Acids | 1 | 2018 | 56 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 165 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2021 | 529 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2024 | 737 | 0.040 |
Why?
| | Neoplasm Grading | 1 | 2019 | 278 | 0.040 |
Why?
| | Indoles | 1 | 2021 | 378 | 0.040 |
Why?
| | Adolescent | 3 | 2019 | 20241 | 0.040 |
Why?
| | Mitosis | 1 | 2019 | 177 | 0.040 |
Why?
| | Perilipin-2 | 1 | 2018 | 36 | 0.040 |
Why?
| | Phagosomes | 1 | 2017 | 43 | 0.040 |
Why?
| | Lipogenesis | 1 | 2017 | 56 | 0.030 |
Why?
| | Sheep | 1 | 2020 | 832 | 0.030 |
Why?
| | Lysosomes | 1 | 2017 | 139 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1014 | 0.030 |
Why?
| | Phosphoserine | 1 | 2015 | 31 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1504 | 0.030 |
Why?
| | Blotting, Western | 2 | 2010 | 1189 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 2015 | 147 | 0.030 |
Why?
| | Corticosterone | 1 | 2016 | 214 | 0.030 |
Why?
| | Adenylate Kinase | 1 | 2014 | 26 | 0.030 |
Why?
| | Caspase 10 | 1 | 2014 | 5 | 0.030 |
Why?
| | Chorionic Gonadotropin | 1 | 2014 | 80 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 935 | 0.030 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2014 | 96 | 0.030 |
Why?
| | Time Factors | 1 | 2004 | 6579 | 0.030 |
Why?
| | GRB2 Adaptor Protein | 1 | 2013 | 13 | 0.030 |
Why?
| | Oxidoreductases | 1 | 2014 | 91 | 0.030 |
Why?
| | Transcription Factors | 1 | 2021 | 1636 | 0.030 |
Why?
| | Transgenes | 1 | 2014 | 180 | 0.030 |
Why?
| | Estradiol Dehydrogenases | 1 | 2012 | 1 | 0.030 |
Why?
| | Incidence | 1 | 2019 | 2635 | 0.030 |
Why?
| | Estrous Cycle | 1 | 2012 | 18 | 0.030 |
Why?
| | Binding Sites | 1 | 2015 | 1239 | 0.030 |
Why?
| | Metabolic Networks and Pathways | 1 | 2013 | 176 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3114 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2050 | 0.020 |
Why?
| | Random Allocation | 1 | 2012 | 352 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2019 | 2344 | 0.020 |
Why?
| | Receptors, Androgen | 1 | 2012 | 143 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2846 | 0.020 |
Why?
| | Dexamethasone | 1 | 2013 | 331 | 0.020 |
Why?
| | Toll-Like Receptor 4 | 1 | 2012 | 294 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2012 | 423 | 0.020 |
Why?
| | Cell Survival | 1 | 2012 | 1085 | 0.020 |
Why?
| | Blood Pressure | 1 | 2016 | 1746 | 0.020 |
Why?
| | Middle Aged | 2 | 2019 | 31024 | 0.020 |
Why?
| | Gene Expression | 1 | 2013 | 1477 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1045 | 0.020 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2007 | 29 | 0.020 |
Why?
| | Carbon Radioisotopes | 1 | 2006 | 35 | 0.020 |
Why?
| | Amniotic Fluid | 1 | 2006 | 79 | 0.020 |
Why?
| | Permeability | 1 | 2006 | 158 | 0.020 |
Why?
| | Cytokines | 1 | 2014 | 1997 | 0.020 |
Why?
| | Protons | 1 | 2006 | 80 | 0.020 |
Why?
| | Aged | 1 | 2024 | 22068 | 0.010 |
Why?
| | Muscle Proteins | 1 | 2006 | 224 | 0.010 |
Why?
| | Ultrasonography, Prenatal | 1 | 2006 | 266 | 0.010 |
Why?
| | Phenotype | 1 | 2005 | 3062 | 0.010 |
Why?
|
|
Jansson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|